Background and purpose: The clinical differentiation between parkinsonism in idiopathic normal pressure hydrocephalus (iNPH) and Parkinson's disease (PD) remains challenging in the initial phase. Whether an early cognitive profiling might support the differential diagnosis of early iNPH and PD was addressed. Methods: Neuropsychological tests of 40 iNPH subjects with early symptoms resembling parkinsonism were retrospectively evaluated together with 47 de novo PD patients (dnPD). Only neuropsychological tests performed within 1 year from the first motor symptom were included. The cognitive spectrum of iNPH and dnPD was also compared with a sample of 70 normal controls. Results: A clear difference in the cognitive profile of iNPH, dnPD patients and normal controls was shown. 65% of iNPH subjects showed a diffuse cognitive impairment, including memory, visuospatial abilities, fronto-executive functioning and attention, whereas only 25.5% of the dnPD patients presented an executive dysfunction. 35% of iNPH and 74.5% of PD patients performed within the normal range (P < 0.05). Conclusion: Subjects with iNPH showed an early and diffuse alteration of cognition with respect to dnPD patients. Performing a prompt and accurate neuropsychological evaluation might support the differential diagnosis of these two conditions of parkinsonism.
Introduction
Idiopathic normal pressure hydrocephalus (iNPH) is a complex syndrome characterized by ventriculomegaly accompanied by a progressive triad of gait disturbance, 'dementia' and incontinence that commonly occurs in the elderly [1] [2] [3] . The diagnosis of iNPH relies on internationally accepted clinical and neuroradiological criteria [3, 4] , but it remains complex as each of the primary iNPH symptoms may present multiple aetiologies. In particular, the early differentiation with Parkinson's disease (PD) represents a diagnostic challenge [1, [5] [6] [7] [8] [9] [10] [11] , even when molecular imaging is performed [12, 13] .
Both iNPH and PD present an insidious onset of motor symptoms, which involve postural and gait control already in an early stage of the disease. Indeed, gait abnormalities represent the presenting symptom in 12%-18% of cases [14, 15] and are a major cause of disability [16, 17] .
These motor similarities are not mirrored by cognitive impairment, which correlates with disease progression in PD but not in iNPH, in which dementia is sometimes the only clinical manifestation [18] . Thus the early evaluation of cognitive profiles in these patients might represent helpful clinical tools for differential diagnosis.
The cognitive performances of a group of early iNPH subjects with a group of early PD patients and aged-matched normal controls (NCs) were compared; then, whether the cognitive impairment of iNPH differs from the cognitive impairment of PD patients was investigated.
Materials and methods
The neuropsychological tests of 40 subjects with iNPH and 47 subjects with PD (from January 2014 to December 2016), referred to our Centre for Parkinson's Disease of Pavia and Pisa (Italy) because of gait disorders and/or postural instability, were retrospectively evaluated. The neuropsychological evaluation is performed in our centres in all patients as a part of diagnostic procedures independently of the suspicion of cognitive dysfunction. The neuropsychological tests performed during the first neurological examination, hence before the confirmation of the diagnosis of iNPH, were identified. Patients were defined as 'early iNPH' when notice of the first motor symptom presentation was within 12 months before cognitive testing. The Institutional Review Board approved the study, and all patients gave written informed consent.
The diagnosis of iNPH was made according to the international evidence-based guidelines of Williams and Relkin [3, 4] . In brief, the main neuro-imaging features were ventricular enlargement not entirely attributable to cerebral atrophy or congenital enlargement (Evans index > 0.3) and no macroscopic obstruction to cerebrospinal fluid flow, accompanied by at least one of the following supportive features: enlargement of the temporal horns of the lateral ventricles not entirely attributable to hippocampal atrophy; narrowing of the sulci and subarachnoid spaces over the high convexity/midline surface; a callosal angle of 40°or more; evidence of altered brain water content, including periventricular signal changes on computed tomography and magnetic resonance imaging (MRI) not attributable to microvascular ischaemic changes or demyelination; an aqueductal or fourth ventricular flow void on MRI. Evidence of relevant antecedent events such as head trauma, intracerebral haemorrhage, meningitis or other known causes of secondary hydrocephalus was excluded as were other neurological, psychiatric or general medical conditions capable of explaining the symptoms [3, 4] . Moreover, all the patients had a positive spinal tap as assessed by means of the sit walk sit test.
Subjects with PD were diagnosed according to the UK Brain Bank criteria as revised by the International Parkinson and Movement Disorder Society (MDS) [19] . Atypical parkinsonian disorders such as multiple system atrophy, progressive supranuclear palsy or corticobasal degeneration and other neurological conditions were considered exclusion criteria. A 1.5 T MRI was performed in all patients to evaluate radiological signs of atypical parkinsonism, neoplastic lesions, extensive vascular damage or hydrocephalus, as described above. All the included patients received during the following year a dopaminergic replacing treatment showing a stable motor improvement as assessed by means of the motor subscore of the Unified Parkinson's Disease Rating Scale (UPDRS-III). At the time of the neurophysiological assessment none of the subjects had ever used any dopaminergic treatment and they are therefore considered de novo PD (dnPD).
The cognitive performances of a sample of 70 healthy elderly subjects (similar for age, sex and education) who were used as the NC group were also collected (from January 2011 to December 2016). These tests belong to our historical archive of hospitalized patients and patients' relatives without peripheral neurological disorders or cognitive impairment.
All the patients and NCs were examined by a neurologist and tested by a neuropsychologist. The following neuropsychological tests were administered to evaluate various cognitive domains:
Mini Mental State Examination (MMSE) [20] : general index of cognitive functioning Digit Span Forward, Word Span and Spatial Span, Corsi's test [21] : working memory Rey's 15-word test [22] , both immediate and delayed recall: long-term verbal memory Logical memory test [21] : long-term verbal memory for structured material Raven's Coloured Matrices 47 [22] : visuospatial reasoning Frontal Assessment Battery (FAB) [23] : frontoexecutive functioning Attentive matrices [21] : selective attention Tests of phonological and semantic fluency [22, 24] : lexical store Constructive apraxia [21] : copying and visuospatial abilities. Age-, gender-and education-corrected scores were calculated from the raw scores; the corrected scores were then used for group comparison.
Statistical analysis
Statistical analysis was performed by means of the JMP statistical package, version 5.1 (SAS Institute, Cary, NC, USA).
Continuous variables were described as mean AE standard deviation and ordinal data as numbers and percentages. One-way analysis of variance (ANOVA) was used to detect significant differences in the cognitive performances between NCs, iNPH and PD. Analyses were corrected for multiple comparisons with Dunnett's test; the level of statistical significance was set at P < 0.05. Moreover, the numbers of subjects who performed within the normality level in the groups of iNPH and dnPD were computed by using the equivalent scoring system, which categorizes the corrected score into five clusters, where 0 represents a pathological performance, 1 the lower limit of normality and 2, 3, 4 normality. The distribution of subjects with cognitive impairment between groups and other comparisons of percentages were performed using the chi-squared test. Finally the involvement of different cognitive domains was described by comparing the performances of specific tests between iNPH and dnPD (ANOVA).
Results

Demographic comparison
The groups were first compared in terms of age, gender, education and the severity of motor impairment as assessed by means of the UPDRS-III. Descriptive statistics are reported in Table 1 . The dnPD subjects were younger than the iNPH and NC subjects; no other difference was found between the three groups ( Table 1) .
Comparison with healthy controls
As shown in Table 2 , the iNPH subjects showed worse cognitive performances in almost all neuropsychological tests with respect to NCs with the exception of the Digit Span forward and Word Span and semantic fluency; no patient could be considered demented. dnPD patients differed from NCs only at fronto-executive functioning (the FAB) and verbal fluency (phonological); however, when Dunnett's test was applied this difference disappeared.
On the basis of the equivalent scoring system, it was found that 14/40 (35%) iNPH and 35/47 (74.5%) dnPD patients performed within the normality level, whilst 26/40 (65%) iNPH and 12/47 (25.2%) dnPD patients were cognitively impaired (v 2 test, P < 0.0002; Fig. 1) . In more detail, 24/26 (92.3%) iNPH patients presented widespread deficits; only 2/26 (7.7%) showed an isolated executive dysfunction. In the dnPD group, all 12 patients presented a cognitive impairment which can be defined as mild cognitive impairment (MCI) single domain -executive according to the MDS criteria [25] .
Cognitive impairment in early iNPH and dnPD
The involvement of different cognitive domains of early iNPH and dnPD are shown in Table 3 .
The general index of cognitive functioning as measured by means of MMSE indicated a striking difference in the overall cognitive performances of the two groups. Subjects with iNPH performed worse than dnPD patients showing a more severe and diffuse impairment of the cognitive status (one-way ANOVA, Dunnett's test corrected, P < 0.01; Fig. 2 ).
Assessing the different domains across the two groups, it was found that working memory (Corsi's test) was more impaired in subjects with iNPH than in dnPD patients (P < 0.01), whereas the Word and The age, education, duration and severity of disease as measured with UPDRS-III are reported as average AE SD; age and education are expressed in years, UPDRS-III as score. Gender distribution is also reported. The statistical comparison between NCs and dnPD and between iNPH and dnPD is indicated as * and **, respectively; this indicates P < 0.05 (Student's t). The mean score of each test is reported (mean AE SD); statistical significance is reported as * for NCs versus iNPH or as ** for NCs versus dnPD; this indicates P < 0.05 (one-way ANOVA).
Digit Span instead did not differ between the groups (P > 0.05, Fig. 2 ). Subjects with iNPH also showed greater deterioration of long-term verbal memory with respect to dnPD patients both in the immediate and delayed recall of Rey's 15-word test (P < 0.01; Fig. 2 ). Similarly, the long-term verbal memory for structured material was more impaired in iNPH subjects with respect to dnPD patients (P < 0.01; Fig. 2) .
The visuospatial reasoning was also more compromised in the iNPH group than in the dnPD group (P < 0.05; Fig. 2) .
The FAB scores showed a greater impairment of fronto-executive functioning in the patients with iNPH in comparison to dnPD subjects (P < 0.01). Selective attention mirrored the FAB results, showing a greater impairment in the iNPH group with respect to the dnPD group (P < 0.01; Fig. 2 ).
The phonological (P < 0.01) but not semantic fluency test (P > 0.05) showed a greater reduction of the lexical store in subjects with iNPH with respect to dnPD (Fig. 2) . Finally, the iNPH group performed worse than the dnPD group in the test for constructive apraxia, thus suggesting a greater impairment of copying and visuospatial abilities (P < 0.01; Fig. 2 ).
Discussion
The main finding of this study is the early difference in the cognitive profile of subjects with iNPH and PD. Subjects with iNPH showed a more severe cognitive impairment with respect to initial PD patients and the control group. Within 1 year from the onset of motor symptoms, only 35% of the iNPH patients were cognitively unimpaired in contrast to 74.5% of early PD patients. Moreover, the cognitive impairment of the subjects with iNPH spread over multiple domains, involving memory, attention and visuospatial abilities; in contrast, the cognitive difficulties of PD were ascribed to executive functions. Subjects with early PD most commonly present only subtle cognitive dysfunction [26] . Only few studies assessed cognitive performances in the initial phase of PD reporting a prevalence of mild cognitive deficits in 19%-36% of the subjects [26] . In a recent study investigating 141 early PD patients, MCI was documented only in 14.8% of the patients, of whom 38.9% were single domain (five non-amnestic, two amnestic) and 61.1% multi-domain (six non-amnestic, five amnestic) [26] . Moreover, MCI in PD subjects was shown to correlate with the severity of the motor symptoms [26, 27] . Our results are substantially in agreement with these data, as a mild cognitive dysfunction was only observed in 25% of PD patients with a moderate motor impairment.
These results corroborate previous studies reporting a wide range of cognitive impairment in subjects with iNPH in which overt dementia was observed in advanced stages of disease [18] . Personal data [28] show similar results in a non-selected group of iNPH patients with a broad disease duration: a diffuse neuropsychological impairment was found, with the extent of statistical significance varying from test to test; only 17% of the whole population presented no cognitive deficits.
The reason of such a wide deficit is not clear; a debate in fact continues to exist about the pathophysiology of this complex condition [29] . More recently, the concept of the glymphatic system was introduced [30] and reduced glymphatic clearance was found in subjects with iNPH, thus suggesting a pathway for the development of dementia in this disease [31] . Further data suggest that aquaporin-4 channels can be implicated in the pathophysiology of iNPH, and a modulation of their activity could be a potential target for pharmacological management [32] . Anyway, it is reasonable to suggest that cognitive symptoms observed in iNPH and PD patients underpin partly the same pathophysiology in the cortical areas and basal ganglia circuits, being more diffuse and severe in iNPH than in PD. Moreover, although the lack of an objective measure of the premorbid cognitive status could have produced an overestimation or underestimation of the occurrence of cognitive deficit, the same education level in patients with iNPH and dnPD should indicate a similar level of cognitive reserve. Despite the large number of patients assessed, the choice of including only those examined within 1 year from the onset of symptoms limited the sample size; larger multicentre studies might account for this problem in the future.
Besides these limitations, the occurrence of an early and wider cognitive decline in subjects with iNPH with respect to PD might support both the differential diagnosis and their early treatment.
Conclusion
It is suggested that the cognitive profiling of iNPH in an early stage of the disease may support the differential diagnosis of PD and a prompt treatment, thus possibly preventing the evolution of cognitive impairment.
